- Home
- INLF vs RANI Comparison
INLF vs RANI Comparison
Compare INLF & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLF
- RANI
- Stock Information
- Founded
- INLF 2016
- RANI 2012
- Country
- INLF China
- RANI United States
- Employees
- INLF N/A
- RANI N/A
- Industry
- INLF Industrial Machinery/Components
- RANI Medicinal Chemicals and Botanical Products
- Sector
- INLF Industrials
- RANI Health Care
- Exchange
- INLF Nasdaq
- RANI Nasdaq
- Market Cap
- INLF 16.2M
- RANI 17.0M
- IPO Year
- INLF 2025
- RANI 2021
- Fundamental
- Price
- INLF $1.07
- RANI $0.65
- Analyst Decision
- INLF
- RANI Strong Buy
- Analyst Count
- INLF 0
- RANI 4
- Target Price
- INLF N/A
- RANI $7.75
- AVG Volume (30 Days)
- INLF 3.6M
- RANI 331.2K
- Earning Date
- INLF 01-01-0001
- RANI 08-05-2025
- Dividend Yield
- INLF N/A
- RANI N/A
- EPS Growth
- INLF 18.78
- RANI N/A
- EPS
- INLF 0.13
- RANI N/A
- Revenue
- INLF $15,796,983.00
- RANI $1,200,000.00
- Revenue This Year
- INLF N/A
- RANI N/A
- Revenue Next Year
- INLF N/A
- RANI N/A
- P/E Ratio
- INLF $8.25
- RANI N/A
- Revenue Growth
- INLF 25.27
- RANI N/A
- 52 Week Low
- INLF $0.77
- RANI $0.46
- 52 Week High
- INLF $21.00
- RANI $4.19
- Technical
- Relative Strength Index (RSI)
- INLF N/A
- RANI 61.01
- Support Level
- INLF N/A
- RANI $0.52
- Resistance Level
- INLF N/A
- RANI $0.68
- Average True Range (ATR)
- INLF 0.00
- RANI 0.04
- MACD
- INLF 0.00
- RANI 0.03
- Stochastic Oscillator
- INLF 0.00
- RANI 83.92
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.